Copyright
©2012 Baishideng.
World J Crit Care Med. Jun 4, 2012; 1(3): 67-79
Published online Jun 4, 2012. doi: 10.5492/wjccm.v1.i3.67
Published online Jun 4, 2012. doi: 10.5492/wjccm.v1.i3.67
Table 1 Mortality in various degrees of severity of sepsis
Diagnosis | Number (1100) | Deaths (%) |
Nil | 421 | 101 (24.0) |
SIRS | 573 | 152 (26.5) |
Sepsis | 50 | 18 (36.0) |
Severe sepsis | 23 | 12 (52.2) |
Septic shock | 33 | 27 (81.8) |
Table 2 Multiple organ dysfunction score
Organ system | Score | ||||
0 | 1 | 2 | 3 | 4 | |
Respiratory PaO2/FiO2 | > 300 | 226-300 | 151-225 | 76-150 | ≤ 75 |
Renal creatinine (μmol/L) | ≤ 100 | 101-200 | 201-350 | 251-500 | > 500 |
Hepatic bilirubin (μmol/L) | ≤ 20 | 21-60 | 61-120 | 121-240 | > 240 |
Cardiovascular PAR1 | < 10.0 | 10.1-15 | 15.1-20 | 20.1-30 | > 30.0 |
Cardiovascular HR (beats/min) | < 120 | 120-140 | > 140 | Dopamine > 3 mg/g per min | Lactate > 5 mmoL/L |
Hematologic platelet count (/L) | > 120 | 81-120 | 51-80 | 21-50 | ≤ 20 |
Neurologic Glasgow coma score | 15 | 13-14 | 10-12 | 7-9 | ≤ 6 |
Table 3 Sequential organ failure assessment score
Organ system | Score | ||||
0 | 1 | 2 | 3 | 4 | |
Respiratory PaO2/FiO2 | > 400 | ≤ 400 | ≤ 300 | ≤ 200 | ≤ 100 |
Renal creatinine (μmol/L) | ≤ 110 | 110-170 | 171-299 | 300-440 urine output ≤ 500 mL/d | > 440 urine output < 200 mL/d |
Hepatic bilirubin (μmol/L) | ≤ 20 | 20-32 | 33-101 | 102-204 | > 240 |
Cardiovascular hypotension | No hypotension | MAP < 70 mmHg | Dopamine ≤ 51 | Dopamine > 51 or epinephrine ≤ 0.11 or norepinephrine ≤ 0.11 | Dopamine > 151 or epinephrine > 0.11 or norepinephrine > 0.11 |
Dobutamine (any dose) | |||||
Hemotologic platelet count (/mL) | > 150 | ≤ 150 | ≤ 100 | ≤ 50 | ≤ 20 |
Neurologic Glasgow coma score | 15 | 13-14 | 10-12 | 6-9 | < 6 |
Table 4 Logistic organ dysfunction score
Organ system | LOD points | ||||||
Increasing severity/decreasing values | Organ dysfunction free | Increasing severity/increasing values | |||||
5 | 3 | 1 | 0 | 1 | 3 | 5 | |
Neurologic Glasgow coma score | 3-5 | 6-8 | 9-13 | 14-15 | |||
Cardiovascular heart rate (min) | < 30 or < 40 | 40-69 | 70-89 | 30-139 | ≥ 140 or 240-269 | ||
Systolic blood pressure (mmHg) | 90-239 | ≥ 270 | |||||
Renal | |||||||
Serum urea (g/L) | < 6 | 6-9.9 | 10-19.9 | ≥ 20 | |||
Serum urea nitrogen (mmol) | < 6 | 6-9.9 or 106-140 | 10-19.9 or ≥ 141 or ≥ 10 | ≥ 20 | |||
Creatinine (μmol) | < 106 | ||||||
Urine output (I/d) | < 0.5 | 0.5-0.74 | 0.75-9.99 | ||||
Pulmonary PaO2/FiO2 on MV or CPAP PaO2 (kPa)/FiO2 | < 150 (< 19.9) | ≥ 150 (≥ 19.9) | No ventilation, no IPAP or no CPAP | ||||
Hematologic | |||||||
White blood cell count (× 109/L) | < 1.0 | 1.0-2.4 or < 50 | 2.5-49.9 | ≥ 50.0 | |||
Plateltes (× 109/L) | ≥ 50 | ||||||
Hepatic bilirubin (μmol/L) | < 34.2 | ≥ 34.2 | |||||
Prothrombin time, seconds above standard (% of standard) | (< 2.5%) | ≤ 3 (≥ 25%) | > 3 |
Table 5 Acute physiology score in Acute Physiology and Chronic Health Evaluation II
Physiological variable | High abnormal range | Low abnormal range | |||||||
4 | 3 | 2 | 1 | 0 | 1 | 2 | 3 | 4 | |
Temperature-rectal (°C ) | ≥ 41 | 39-40.9 | 38.5-38.9 | 36-38.4 | 34-35.9 | 32-33.9 | 30-31.9 | ≤ 29.9 | |
Mean arterial pressure (mmHg) | ≥ 160 | 130-159 | 110-129 | 70-109 | 50-69 | ≤ 49 | |||
Heart rate (ventricular response) | ≥ 180 | 140-179 | 110-139 | 70-109 | 50-69 | 40-54 | ≤ 39 | ||
Respiratory rate (non-ventilated or ventilated) | ≥ 50 | 35-49 | 25-34 | 12-24 | 10-11 | 6-9 | ≤ 5 | ||
Oxygenation | |||||||||
A-a DO2 (mmHg) | |||||||||
FiO2≥ 0.5 | ≥ 500 | 350-499 | 200-349 | < 200 | |||||
Record | |||||||||
A-a DO2 (mmHg) | |||||||||
FiO2 < 0.5 record only PaO2 | PO2 > 70 | PO2 (6-70) | PO2 (55-60) | PO2 < 55 | |||||
Arterial pH | ≥ 7.7 | 7.6-7.69 | 7.5-7.59 | 7.33-7.49 | 7.25-7.32 | 7.15-7.24 | < 7.15 | ||
Serum sodium (mmol/L) | ≥ 180 | 160-179 | 155-159 | 150-154 | 130-149 | 120-129 | 111-119 | < 7.15 | |
Serum potassium (mmol/L) | ≥ 7 | 6-6.9 | 5.5-5.9 | 3.5-5.4 | 3-3.4 | 2.5-2.9 | < 2.5 | ||
Serum creatinine (10 mg/L) (double point score for acute renal failure) | ≥ 3.5 | 2-3.4 | 1.5-1.9 | 0.6-1.4 | < 0.6 | ||||
Hematocrit (%) | ≥ 60 | 50-59.9 | 46-49.9 | 30-45.9 | 20-29.9 | < 20 | |||
White blood count (total/mm3) (in 1000) | ≥ 40 | 20-39.9 | 15-19.9 | 3-14.9 | 1-2.9 | < 1 | |||
GCS: score = 15 minus actual GCS | |||||||||
Total APS: Sum of the 12 individual variable points | |||||||||
Serum HCO3 (venous-mmol/L) (not preferred, use if no ABG) | ≥ 52 | 41-51.9 | 32-40.9 | 22-31.9 | 18-21.9 | 15-17.9 | < 15 |
Table 6 Acute physiology score in Acute Physiology and Chronic Health Evaluation III scoring system
Parameter | Value range | Points | Parameter | Value range | Points |
Core temperature (°C) | 0-32.9 | 20 | Plasma bilirubin (μmol/L) | 0-34 | 0 |
33.0-33.4 | 16 | 35-51 | 5 | ||
33.5-33.9 | 13 | 52-85 | 6 | ||
34.0-34.9 | 8 | 86-135 | 8 | ||
35.0-35.9 | 2 | 136 plus | 16 | ||
36.0-36.9 | 0 | ||||
40 or more | 4 | ||||
Heart (r/min) | 0-39 | 8 | Urine volume (mL/24 h) | 0-399 | 15 |
40-49 | 5 | 400-599 | 3 | ||
50-99 | 0 | 600-899 | 7 | ||
100-109 | 1 | 900-1499 | 5 | ||
110-119 | 5 | 1500-1999 | 4 | ||
120-139 | 7 | 2000-3999 | 0 | ||
140-154 | 13 | 4000 plus | 1 | ||
155 or more | 17 | ||||
Mean blood pressure (mmHg) | 0-39 | 23 | Plasma Creatinine (μmol/L) (if no acute renal failure) or in ARF (< 410 mL urine vol/24 h) | 0-43 | 3 |
40-59 | 15 | 44-132 | 0 | ||
60-69 | 7 | 133-171 | 2 | ||
70-79 | 6 | 172 or more | 7 | ||
80-99 | 0 | ||||
100-119 | 4 | ||||
120-129 | 7 | 0-132 | 0 | ||
130-139 | 9 | 133 or more | 10 | ||
140 or more | 10 | ||||
Respiratory (r/min) (zero points for 6-12/min rate if on ventilation) | 0-5 | 17 | Arterial PO2 (kPa) (Inspired O2 < 50%) or alveolar/arterial PO2 difference kPa (Pa-PaO2) (Inspired O2 > 50%) | 0-6.66 | 15 |
6-11 | 8 | 6.67-9.32 | 5 | ||
12-13 | 7 | 9.33-10.6 | 2 | ||
14-24 | 0 | 10.7 plus | 0 | ||
25-34 | 6 | ||||
35-39 | 9 | 0-13.2 | 0 | ||
40-49 | 11 | 13.3-33.2 | 7 | ||
50 or more | 18 | 33.3-46.5 | 9 | ||
46.6-66.6 | 11 | ||||
66.7 and over | 14 | ||||
White cell count (× 109/L) | 0-0.9 | 19 | Age (yr) | 0-44 | 0 |
1.0-2.9 | 5 | 45-59 | 5 | ||
3.0-19.9 | 0 | 60-64 | 11 | ||
20.0-24.9 | 1 | 65-69 | 13 | ||
25 or more | 4 | 70-74 | 17 | ||
75 or more | 24 | ||||
Haematocrit (%) | 0-49.9 | 0 | Chronic health evaluation (do not score in elective surgery patients) | Cirrhosis Immunosuppression Leukaemia Multiple myeloma | 4 |
50 or more | 3 | 10 | |||
10 | |||||
10 | |||||
Plasma sodium (mmol/L) | 0-119 | 3 | Metastaic cancer | 11 | |
120-134 | 2 | Lymphoma | 13 | ||
135-154 | 0 | Hepatic failure | 16 | ||
155 or more | 4 | AIDS | 23 | ||
Plasma albumin (g/L) | 0-19 | 11 | Neurological score | Use matrix | 0-48 |
20-44 | 0 | ||||
45 or more | 4 | ||||
Acid base status | Use matrix | 0-12 |
- Citation: Moemen ME. Prognostic categorization of intensive care septic patients. World J Crit Care Med 2012; 1(3): 67-79
- URL: https://www.wjgnet.com/2220-3141/full/v1/i3/67.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v1.i3.67